Company No: 14361627 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		30.09.2024		30.09.2023
		£		£
Fixed assets		675		489
Current assets		76,626		28,331
Creditors: amounts falling due within one year		( 11,040)		( 5,129)
Net current assets		65,586		23,202
Total assets less current liabilities		66,261		23,691
Accruals and deferred income		( 1,513)		( 1,753)
Net assets		64,748		21,938
Capital and reserves		64,748		21,938

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Severn Health Limited (registered number: 14361627) were approved and authorised for issue by the Board of Directors on 01 September 2025 and were signed on its behalf by:

Dr James Swee Beng Kho Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 14361627). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

	Year ended 30.09.2024		Period from 16.09.2022 to 30.09.2023
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	2		2